• Elcelyx Therapeutics Raises $4 Million More...

• Arrowhead Research Corporation (ARWR) Raises $6.2 Million Through Registered Direct Offering of Common Stock and Warrants More...

• Sun Pharmaceutical Industries Ltd to Take Taro Pharmaceutical Industries Ltd. (TARO) Private for $571 Million More...

• Quintiles, Inc. (QTRN) Acquires Expression Analysis, Inc., Premier Provider of Genomics Services, to Advance Personalized Medicine More...

• Pluristem Therapeutics (PSTI) Moves Intermittent Claudication Indication Forward in Europe Through Collaboration With Cato Research More...

• Sequenta's LymphoSIGHT™ Platform Included in Phase II Mantle Cell Lymphoma Clinical Trial More...

• Molecular Profiles and Onyx Scientific Limited Form Strategic Alliance Spanning Drug Discovery to Manufacture More...

• InSite Vision (ISV) & Merck & Co., Inc. (MRK) Amend Payment Terms of AzaSite® License Agreement More...

• NewBridge Pharmaceuticals Forms Partnership With Genomic Health, Inc. to Bring Novel Genomic Testing to Patients in Middle East, Africa, and Caspian Regions More...

• Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors More...

• AccelPath, Inc. Appoints Professor Leslie F. Greengard, M.D., Ph.D. to the Company's Medical Advisory Board More...

• Cytomedix Inc. (CMXI) to Host Second Quarter 2012 Financial Results Conference Call on Wednesday, August 15, 2012 More...

• Echo Therapeutics (ECTE) Announces Second Quarter 2012 Financial Results More...

• GeoVax Labs Inc. (GOVX.OB) Reports 2012 Second Quarter Financial Results More...

• Galectin Therapeutics Reports Second Quarter 2012 Financial Results More...

• ImmuCell (ICCC) Announces Profitable Financial Results More...

• Novo Nordisk A/S (NVO)'s Hemophilia Tx Could be a Total Bust More...

• Acorda Therapeutics (ACOR)' Ampyra Fails Main Goal of Post-Marketing Study More...

• Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients With Eosinophilic Esophagitis More...

• Protalix Biotherapeutics, Inc. (PLX) Receives FDA IND Clearance to Initiate a Phase I/II Study of Fabry Disease Patients With PRX-102, a Modified Enzyme Replacement Therapy More...

• Vernalis PLC (VNLPY.PK) to Present Positive Phase I Data for V158866 at14th World Congress on Pain More...

• FDA OKs Sanofi (France) (SAN.PA)'s Auvi-Q for Patients With Life-Threatening Allergic Reactions More...

• NPS Pharmaceuticals, Inc. (NPSP) Announces Extension of Action Date for Gattex® NDA to December 30, 2012 More...

• Teva Women's Health, Inc. (TEVA) Receives FDA Acceptance of Its New Drug Application for Quartette™ (Levonorgestrel/Ethinyl Estradiol Tablets and Ethinyl Estradiol tablets) for the Prevention of Pregnancy More...

• Daily Aspirin May Cut Cancer Deaths, Journal of the National Cancer Institute Reveals More...

• Migraines Do Not Hurt Your Brain, Brigham and Women's Hospital Study More...

• Smelling a Skunk After a Cold, Northwestern University Feinberg School of Medicine Study More...

• University of Western Ontario Researchers Explore Secret Origin of Deja Vu More...

• How Stress and Depression Can Shrink the Brain, Yale University Study More...

• Galena Biopharma (RXII) Issued Folate Binding Protein (FBP) Cancer Vaccine Patent in Japan More...

• Roche (RHHBY) Requested by National Institute for Clinical Excellence (NICE) to Provide Further Zelboraf Data More...

• Fresenius Kabi AG Threatens to Sue Doc Over Study More...

• Applied DNA Sciences, Inc. (APDN) SigNature® DNA Sends UK Thieves to Jail for 53 Years More...

• KV Pharmaceutical Wins a Makena Ruling in Georgia More...